4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-24-000782
SVP, Gen Counsel & Corp Sec sold 1,667 shares at an average $63.93 ($106,579)
- SVP, Gen Counsel & Corp Sec acquired 1,667 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2024-01-02 | Option exercise 10b5-1 | +1,667 | $21.41 | $35,690 | 22,377 | D: show line 1 in the form |
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2024-01-02 | Sale 10b5-1 | −141 | $62.91 | $8,871 | 22,236 | D: show line 2 in the form |
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2024-01-02 | Sale 10b5-1 | −598 | $63.59 | $38,029 | 21,638 | D: show line 3 in the form |
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2024-01-02 | Sale 10b5-1 | −928 | $64.31 | $59,680 | 20,710 | D: show line 4 in the form |
| Open-market sales · 1,667 sh · avg $63.93 · $106,579 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, Gen Counsel & Corp Sec | 2024-01-02 | Option exercise · Stock Option (right to buy) 10b5-1 | +1,667 | 193,333 | D: show line 5 in the form |
Loading xslF345X05/doc4.xml…